Navigation Links
Abraxane in Medical News

Drug May Extend Life When Breast Cancer Spreads

... -- A new study affirms that the chemotherapy drug abraxane is more effective, with less troublesome side effe...tic breast cancer. When compared with Taxotere, abraxane extended the time before a recurrence by almost se...een presented at national meetings, reaffirms that abraxane is a very active drug, is well-tolerated and appea...

NYU Langone Medical Center's tip sheet to the 44th annual meeting of ASCO

...the feasibility and efficacy of the triple combination of oblimersen (OBL), abraxane (ABX), and temozolomide (TMZ) in metastatic melanoma and normal LDH NYU C...with metastatic melanoma received a therapy that combined oblimersen (OBL), abraxane (ABX) and temozolomide (TMZ). All 14 enrolled patients belonging to the fir...

Study looks at new bladder cancer therapy for patients unresponsive to standard treatment

...nter are investigating an FDA-approved metastatic breast-cancer drug called abraxane that may prove a safe and effective alternative to surgery for these patien...inistration at higher concentrations," says Dr. McKiernan. "In one study of abraxane for metastatic breast cancer, the drug successfully shrank tumors and had f...
Abraxane in Medical Technology

Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology

...92 Saturday, May 31, 2008. -- A Phase I/II Study to Determine the Feasibility and Efficacy of the Triple Combination of Oblimersen (OBL), abraxane (ABX), and Temozolomide (TMZ) in Metastatic Melanoma and Normal LDH. Poster # 16 Abstract No: 9027 Sunday, June 1, 2008. -- Effect of the...

Genasense(R) Data in Patients with Advanced Melanoma to be Featured at 4th International Melanoma Congress

...naive patients with advanced melanoma and low LDH. Presenter: A. Bedikian. A Phase I study of the triple combination of oblimersen, temozolomide, and abraxane in patients with advanced melanoma and normal LDH. Presenter: A. Pavlick. Pharmacokinetics of oblimersen in combination with dacarbazine in metastati...

Abraxis BioScience Presents Data from Pre-Clinical Study That Provide Evidence for Chemotherapy-Induced Angiogenesis and Rationale for Combining nab-Paclitaxel (Abraxane) with Anti-Angiogenic Agents to Increase Tumor Response

...d. The most serious adverse events associated with abraxane in the randomized metastatic breast cancer study f... for ABRAXANE(R), please visit www.abraxane.com. abraxane was developed by Abraxis BioScience, Inc. abraxane is marketed in the United States under a co-promot...

Abraxis BioScience Presents Pre-Clinical Findings That Support Role of SPARC Expression in Cancer and the Role of the Nanoparticle Albumin Bound (nab) Technology Platform in Targeting the Pathway

...G HSP90 inhibitor (ABI 010), among others. About abraxane (R) The U.S. Food and Drug Administration approved abraxane (R) for Injectable Suspension (paclitaxel protein-...d. The most serious adverse events associated with abraxane in the randomized metastatic breast cancer study f...
Abraxane in Biological News

2 new therapies show promise for cancer patients

... The fact that we saw this kind of activity in a phase I trial is dramatic, Von Hoff said. The rationale behind the combination of Gemcitabine plus abraxane was based on careful science and was designed and executed by some of the leading experts in pancreas cancer in the world. While the data is prelimina...

Nanoparticle Breast Cancer Drug Approved by FDA

...t role in Food and Drug Administration approval of abraxane (paclitaxel protein-bound particles for injectable...the more common treatments showed improvement with abraxane and experienced less-severe side effects that made treatment more tolerable," Gradishar said. abraxane is engineered using a proprietary process (protein...
Abraxane in Biological Technology

Midwest large cap life science group strengthening in the third quarter

...l listing price on the NYSE. American Pharmaceutical Partners has also been on a roll ever since new CEO Al Heller took charge and its new cancer drug abraxane was approved by the FDA and has launched. A number of companies continued to suffer during the year including Abbott and Eli Lilly. Abbott was se...
Other Tags
(Date:12/17/2014)... Project Veritas is releasing a video interview ... economist and Obamacare architect Jonathan Gruber to public attention. ... interview, which is being distributed on YouTube. , During ... in the Affordable Care Act in order to hide ... dollar per year tax grab. , “President Obama promised ...
(Date:12/17/2014)... By Alan Mozes ... -- In the world of infectious diseases, one worrisome phenomenon ... into people. The process -- known as zoonosis -- ... they look for signs that an animal-borne disease might make ... on just such a development -- and the culprits in ...
(Date:12/17/2014)... 2014 (HealthDay News) -- Poor students get more fruits and ... study finds. But, the opposite is true for students ... and vegetables at school may give a healthy boost to ... matter what the family income level, students all ate a ... found. The study was published recently in the journal ...
(Date:12/17/2014)... Alan Mozes HealthDay Reporter ... party season fast approaching, a new study reveals that states ... have fewer drunk drivers on their roads. The finding ... are better able to deter inebriated revelers from getting behind ... laws are being passed regarding drinking and driving," said study ...
(Date:12/17/2014)... Kathleen Doheny HealthDay Reporter , ... is rampant in America, and work commitment is a big ... 1 sleep killer," said Dr. Mathias Basner, an assistant professor ... Pennsylvania Perelman School of Medicine. A time-use survey of ... work is the main activity exchanged for sleep. Short sleepers ...
Breaking Medicine News(10 mins):Health News:Project Veritas: James O’Keefe Interviews the Man Who Discovered Jonathan Gruber Videos 2Health News:Guinea Pigs Can Be Source of Serious Strep Infection 2Health News:Guinea Pigs Can Be Source of Serious Strep Infection 3Health News:Poor Students Eat Healthier Foods at School, Study Finds 2Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 2Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 3Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3
(Date:12/10/2014)... 9, 2014 CIE San Diego has launched ... the connective tissue that enhances care coordination among social ... share client-level information; earned a second $1 million grant ... serving seniors aging in community and; will be recognized ... 11 th 4-6p. CIE San Diego ...
(Date:12/5/2014)... Utah , Dec. 4, 2014  Tute Genomics, ... raised $2.3 million in Series A1 funding led by ... investors also participated in the investment round. ... the healthcare community adopts next-generation sequencing and seeks new ... said Reid Robison , MD MBA, and CEO ...
(Date:11/21/2014)... According to a new market ... RFID, Access Control, Intrusion Detection, Parking Management, Under Vehicle ... Service Geography - Global Forecasts to 2020", published by ... be around $25 Billion in 2014 and is expected ... CAGR of 8.69%. Browse 116 market data ...
Breaking Biology News(10 mins):Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3
Other Contents